Covaxin: Get Latest News, Photos and Videos along with latest updates on Covaxin | Hindustan Times
close_game
close_game
[

covaxin news

]

Latest from covaxin

‘Working to improve research ecosystem’: BHU conveys regret

Researchers from the Banaras Hindu University that conducted a study on the safety of Covaxin have conveyed their regret to the Indian Council of Medical Research (ICMR) for acknowledging the support of the apex biomedical research regulator without proper authorisation

File photo of Banaras Hindu University. (HT Archive)
Updated on May 22, 2024 08:50 AM IST

ICMR distances itself from safety study on Covaxin

ICMR distances itself from BHU study on Covaxin safety, threatens legal action against authors for unauthorized acknowledgment.

ICMR collaborated with Bharat Biotech on developing the inactivated vaccine. (Pratham Gokhale/HT Photo)
Updated on May 21, 2024 12:19 AM IST
By, New Delhi

Covaxin study: Amid concern of adverse events, should vaccine takers be worried?

1 in 3 Covaxin takers have reported adverse events as per a new study by BHU. What are these side effects and should people who got jabbed need to worry?

Serious AESI, including stroke and Guillain-Barre syndrome, were reported in around one per cent of individuals as per the study.(HT_PRINT)
Published on May 17, 2024 05:00 PM IST
By, New Delhi

1 in 3 Covaxin takers reported adverse events, BHU study claims

Nearly 50 per cent of the participants complained of infections during the follow-up period, predominated by viral upper respiratory tract infections.

India's vaccination drive was largely powered by two vaccines — Covaxin and Covishield.(Sunil Ghosh/HT Photo)
Published on May 16, 2024 07:45 PM IST

‘Safety is primary focus’: Covaxin-developer amid reports on AstraZeneca vaccine

It stated that Covaxin was the "only Covid vaccine" in government of India's COVID-19 immunisation program to have conducted efficacy trials in India.

Bharat Biotech, further said in its statement that Covaxin was evaluated in more than 27,000 subjects as part of its licensure process.(HT_PRINT)
Published on May 02, 2024 07:24 PM IST
ANI |

First ever comparative study reveals that Covishield outperformed Covaxin

The study was carried out by a group of 11 institutes, led by scientists from the National Centre for Biological Sciences.

A vial of the Covishield vaccine. (FILE PHOTO)
Updated on Mar 08, 2024 07:26 AM IST

CHASCON- 2023: India’s space missions, vaccine supremacy in focus on Day 1

India's 'vaccine war' and space exploration program were the highlights of Day 1 of the Chandigarh Science Congress. India's success in vaccine production and its space missions were discussed by experts. The event will continue for three days.

Dr Balram Bhargava, former director general of the Indian Council of Medical Research, speaking about the India’s role in providing Covid vaccines to the world. (HT PHOTO)
Updated on Oct 13, 2023 09:44 AM IST
By, Chandigarh

Sudha Murty reacts after watching Vivek Agnihotri’s The Vaccine War

Vivek Agnihotri received praise for his film The Vaccine War depicting the development of the Covaxin vaccine. Sudha Murty called it a ‘heart-touching’ tale.

Sudha Murty at the screening of The Vaccine War with Pallavi Joshi and Vivek Agnihotri.
Published on Sep 19, 2023 12:22 PM IST

Intranasal Covid-19 vaccine sees low response on Day 1

Mumbai's rollout of the intranasal Covid-19 vaccine saw a low response on the first day with only 23 senior citizens taking the booster dose. The vaccine, iNCOVACC by Bharat Biotech, will be administered to those above the age of 60 and eligible six months after their second dose of either Covishield or Covaxin. The state health department recently procured 2 lakh doses, of which BMC procured around 2,000 doses. The vaccine will be given through spot registration at 24 centres across Mumbai.

HT Image
Updated on Apr 28, 2023 11:53 PM IST

Poor response to booster dose in Pune as vaccination resumes

PMC health officials since April 1 ran out of vaccine stock and were waiting for the vaccine supply. The civic body this week received 512 doses of the nasal vaccine iNCOVACC

The vaccination centres will be closed on Sunday and Monday. (REPRESENTATIVE PIC)
Updated on Apr 28, 2023 11:51 PM IST
ByVicky Pathare

Few takers for booster jabs as Covid-19 cases decline in Bihar

The state reported 179 fresh cases on Wednesday. The daily new cases have been declining since April 22 when the state reported the month’s highest single-day spike of 198 infections

Patna administered only 224 shots of the Corbevax vaccine since April 16 (Representative Photo)
Updated on Apr 28, 2023 08:14 PM IST

BMC to roll out intranasal Covid vaccine for senior citizens

The vaccination drive will take place in 24 centres – one in every civic ward – across the city. The vaccine will be given through spot registration and addresses of all the locations will be posted daily on BMC’S Twitter account.

HT Image
Updated on Apr 28, 2023 12:34 AM IST

Spike in cases prompts Maharashtra to seek 0.2mn Covid vaccine from Centre

Amidst the surge in Covid-19 cases in the state and vaccine shortage, Maharashtra government has sought 0.2 million Covid vaccine doses from the Centre

Amidst the surge in Covid-19 cases in the state and vaccine shortage, Maharashtra government has sought 0.2 million Covid vaccine doses from the Centre. (HT FILE)
Updated on Apr 14, 2023 01:48 AM IST
ByVicky Pathare

Ludhiana hospitals run out of vaccine as Covid cases rise, last jab given on March 28

Government as well as major private hospitals across Ludhiana, including Dayanand Medical College and Hosptial (DMCH), Apollo hospital and Christian Medical College (CMC) are facing shortage of vaccine stock

As per the data from Integrated Disease Surveillance Programme (IDSP) Department of Health & Family Welfare Punjab, Ludhiana district reported 41 Covid-19 cases in March (HT File Photo)
Updated on Apr 12, 2023 11:56 PM IST
ByDinkle Popli, Ludhiana

Covovax to be available on CoWIN as booster dose soon. Check details

Covovax is likely to be available on the portal in a few days at a price of ₹225 per dose plus applicable GST.

Covovax can be administered to those who have already vaccinated with Covishield or Covaxin. (AFP)
Published on Apr 10, 2023 05:00 PM IST
PTI |

Bihar’s unmet demand of vaccine goes up with Covid cases

Over 3.49 crore precautionary doses or as many people are still to take their precautionary dose among the 5.9 crore adult population in the state, said health officials.

A health official collects swab samples for Covid-19 testing in Patna on Saturday. (HT Photo)
Updated on Apr 09, 2023 10:34 PM IST

Amid Covid surge, Tricity short of vaccine doses

Since April 1, residents of Chandigarh have been unable to receive the Covid-19 vaccine as stock ended by March 31. The local health department has reached out to the Government of India for additional vaccine supplies, but there is currently no information on when the fresh stock will arrive.

Over the past week, numerous individuals have been turned away empty-handed from dispensaries and hospitals as a shortage of vaccines has left them unable to receive their much-needed jabs. (AFP)
Updated on Apr 09, 2023 02:05 AM IST
ByRobert Abraham, Chandigarh

Serum institute seeks to add Covovax on CoWIN portal as booster dose for adults

Last month, COVID-19 Working Group also recommended to the health ministry inclusion of Covovax on the CoWIN portal as a heterologous booster dose for adults.

The letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) on March 27, they said.(HT_PRINT)
Published on Apr 03, 2023 08:10 PM IST
PTI |

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch

Nearly 200 million Corbevax vaccine of Biological E and 50 million of Bharat Biotech's Covaxin are stockpiled at the moment.

Covid: 250 million Corbevax, Covaxin in stock, ready for dispatch.(Reuters/ Representational)
Updated on Dec 28, 2022 01:44 PM IST
By, New Delhi

Covaxin approval sparks questions and clarifications

On November 15, Boston-based health news website Stat News cited official documents that purported to detail a series of problems in how Bharat Biotech’s coronavirus vaccine, funded partly by the government, was approved.

Representational image(HT_PRINT)
Updated on Nov 18, 2022 03:29 PM IST
By, New Delhi

Covid-19 travel update: Japan approves Covaxin booster dose for travellers

Quarantine Station of Japan's Ministry of Health, Labour and Welfare issued an advisory for the Quarantine period after entering Japan. It has approved Covaxin booster dose for travellers

Covid-19 travel update: Japan approves Covaxin booster dose for travellers (HT_PRINT)
Updated on Aug 06, 2022 06:31 PM IST
ANI | | Posted by Zarafshan Shiraz, Hyderabad [telangana]

Germany to recognise Covaxin for travel from June 1

In November last year, the World Health Organisation recommended Emergency Use Listing (EUL) status for Covaxin. Several countries including Australia, Japan and Canada allow passengers vaccinated with Covaxin into those countries.

Bharat Biotech’s Covid-19 vaccine Covaxin. (HT photo)
Published on May 26, 2022 02:05 PM IST
PTI | , Hyderabad

Govt studying BCG vaccine use as Covid booster shot after Covaxin

BCG vaccine primarily provides protection against tuberculosis and has been administered to newborns as part of Centre’s National Immunization Programme for the least 50 years.

A healthcare worker administers a dose of the Covid-19 preventive vaccine to a beneficiary, at a vaccination camp in Gurugram. (PTI)
Updated on May 26, 2022 03:38 AM IST
By, New Delhi:

India clears 2 vaccines for kids under 12 years

While Corbevax was approved by the Drugs Controller General of India (DCGI) for administration in children aged 5-12 years, Covaxin was cleared for use in those aged 6-12 years.

A healthcare worker administers a dose of the Corbevax vaccine to a child. (HT file photo)
Updated on Apr 27, 2022 06:01 AM IST
By, New Delhi:

Covaxin cleared by drug regulator for 6-12 year olds, Corbevax for 5-12 bracket

Covaxin has been developed by Bharat Biotech in collaboration with the ICMR. 

Covaxin is one of the two most widely used vaccines in India. (HT PHOTO.)(HT_PRINT)
Published on Apr 26, 2022 01:18 PM IST
By | Edited by Swati Bhasin

'Strenghten the fight' against Covid: Health minister on booster shots for 18+

Booster doses: At private vaccine centres, there is an option of both "walk-in" and "online appointment" via the government platform for registration - CoWIN.

India began the rollout of booster doses from Sunday. (HT FILE PHOTO)
Published on Apr 10, 2022 10:22 AM IST

Covishield, Covaxin costs cut to 225 per dose for private hospitals

Hyderabad-based Bharat Biotech’s Covaxin vaccine earlier cost ₹1,200 per dose in private hospitals, and Pune-based Serum Institute of India was selling its Covishield vaccine at ₹600 per dose.

A senior citizen gets inoculated with a booster dose of Covid vaccine, in Noida. (Sunil Ghosh/HT photo)
Updated on Apr 10, 2022 02:55 AM IST
By, Hindustan Times, New Delhi

Day before 'precautionary' doses for all, Covishield, Covaxin prices slashed

The prices of SII's Covishield and Bharat Biotech's Covaxin vaccine have been slashed to ₹225 per dose at private hospitals.

Covishield (left) and Covaxin (right) prices slashed at <span class='webrupee'>₹</span>225 per dose at private hospitals
Updated on Apr 09, 2022 04:15 PM IST
Written by Manjiri Sachin Chitre | Edited by Chandrashekar Srinivasan

WHO suspends Covaxin supplies under UN procurement

This suspension is in response to the outcomes of WHO post emergency use listing inspection conducted between March 14 – 22, and the need to conduct process and facility upgrade to address recently identified good manufacturing practice (GMP) deficiencies.

The World Health Organization (WHO) has suspended the supply of Bharat Biotech’s anti-Covid vaccine, Covaxin, under the Covax facility, the UN health body announced on Saturday. (HT PHOTO.)
Updated on Apr 03, 2022 04:12 AM IST

Covaxin production to be temporarily slowed down 'foreseeing decrease in demand'

In a statement, the vaccine manufacturer said: “For the coming period, the company will focus on pending facility maintenance, process and facility optimization activities.

Covaxin got the WHO's approval for emergency use last year. ((PIC FOR REPRESENTATION))
Published on Apr 02, 2022 06:58 AM IST
By | Edited by Swati Bhasin
SHARE
  • 1
  • 2
  • 3
  • ...
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Saturday, May 25, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On